BTG reiterates full-year guidance
16th Jul 2014 11:41
- FY revenue guidance unchanged - Trading in line - US investigating LC Bead Healthcare company BTG has left its full-year revenue guidance unchanged, saying trading has been in line with expectations. Full-year revenue is expected to be in the £330m to £345m range, despite the recent weakening of
Read moreWednesday broker round-up UPDATE
2nd Jul 2014 09:38
Anite: Investec places its target price (prev.: 88p) under review, while its hold recommendation remains unchanged. Ashcourt Rowan: N+1 Singer moves target price from 231p to 242p and keeps a buy recommendation. BG Group: Canaccord Genuity raises target price from 1250p to 1450p upgrading from hol
Read moreSector movers: Shire soars as M&A fever boosts pharma, health stocks
20th Jun 2014 13:56
News that Shire has rejected a £27bn approach by AbbVie sent shares in the pharmaceutical and healthcare equipment sectors higher on Friday as yet more M&A continued to give sentiment a boost. "A bit of M&A excitement has been just the ticket to enliven trading on what may otherwise have been somet
Read moreFTSE 250 movers: Go-Ahead soars on Thameslink win
23rd May 2014 14:33
A joint venture of bus and train operator Go-Ahead and a company part-owned by French state railway SNCF has won the battle to run the new Thameslink rail super-franchise in London and south-east England. The announcement was bad news for rival bidders FirstGroup, which already runs the Thameslink
Read moreLondon midday: FTSE continues to decline, Intertek drags lower
23rd May 2014 11:40
- FTSE down 16.44 points to 6,804.12 - Intertek hit by Numis comments - Elections in focus ahead of Bank Holiday weekend techMARK 2,747.39 +0.12% FTSE 100 6,799.91 -0.30% FTSE 250 15,677.95 +0.02% The FTSE was still down by midday, dragged lower by Intertek ahead of the long weekend which will see
Read moreLondon open: FTSE falls, Smiths and Tullow drag, elections in focus
23rd May 2014 08:55
- Smiths and Tullow disappoint - FTSE opens 16 points lower - Ukraine, European elections in focus techMARK 2,741.75 -0.09% FTSE 100 6,801.45 -0.28% FTSE 250 15,657.08 -0.11% The FTSE opened lower this morning, falling around 16 points in the first hour of trade, weighed by disappointing announcem
Read moreBTG pulmonary embolism treatment granted FDA clearance in US
23rd May 2014 07:57
BTG has been granted clearance for its EkoSonic Endovascular System treatment of pulmonary embolism (PE) by the US Food and Drug Administration (FDA). The minimally invasive treatment carries out the ultrasound-facilitated, controlled and selective infusion of physician-specified fluids, including
Read moreThursday broker round-up UPDATE
22nd May 2014 08:34
ASOS: Goldman Sachs reduces target price from 7300p to 6250p, while upgrading to buy. BTG: N+1 Singer shaves target price from 488p to 486p retaining a sell recommendation. EKF Diagnostics: FinnCap initiates with a target price of 38p and a buy recommendation. Exova Group: Credit Suisse starts wi
Read moreBTG beats consensus after transformational year
20th May 2014 10:21
Revenues and profits were ahead of consensus forecasts for speciality healthcare group BTG for the year to end-March, although guidance for the new financial year may have disappointed some investors. For the year just gone, reported revenue including the impact of acquisitions was 24% higher at £
Read moreTuesday broker round-up UPDATE
20th May 2014 07:58
Alent: UBS lowers target price from 360p to 355p and keeps a buy recommendation. APR Energy: Investec reduces target price from 1150p to 880p and stays with its hold recommendation. ARM Holdings: Goldman Sachs reduces target price from 1450p to 1400p and stays with its buy recommendation. AVEVA H
Read moreSector movers: M&A boosts pharma sectors as AstraZeneca soars
28th Apr 2014 14:07
M&A activity was continuing to drive the global pharmaceutical sector higher today after Pfizer confirmed it was working on its next move after its first tentative approach for AstraZeneca in January was rejected. Shares in the Anglo-Swedish group were up around 15% at 4,705p in afternoon trade af
Read moreSector movers: M&A gives pharma stocks a big boost
22nd Apr 2014 15:28
Pharmaceuticals and biotechnology stocks were rising by an average of six per cent in London on Tuesday, helped by a wave of high-profile M&A deals across the global healthcare sector. Leading the charge in the UK was AstraZeneca on reports that it could be at the centre of the largest deal in phar
Read moreLondon midday: Pharma deals lift stocks as FTSE 100 nears 6,700
22nd Apr 2014 11:36
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,741.04 +2.28% FTSE 100 6,691.88 +1.01% FTSE 250 16,103.19 +1.23% Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues
Read moreLondon open: Pharma M&A gives UK stocks a lift
22nd Apr 2014 08:59
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,729.51 +1.85% FTSE 100 6,683.16 +0.87% FTSE 250 16,031.64 +0.78% Strong gains from heavyweight pharmaceutical groups gave UK markets a boost on Tuesd
Read moreFriday broker round-up UPDATE
4th Apr 2014 10:07
African Minerals: Deutsche Bank reduces target price from 382p to 335p, while its buy recommendation remains unchanged. Arrow Global: Canaccord Genuity moves target price from 309p to 318p and keeps a buy recommendation. Ashmore Group: JP Morgan takes target price from 344p to 351p and maintains a
Read more